Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Rennova Health, Inc. (the Company) regrets to report the death of
one of its directors, Benjamin Frank, who passed away on December
18, 2016. Mr. Frank had served as a director of the Company since
November 2, 2015 and previously served as a director of Medytox
Solutions, Inc. from April 24, 2013 to November 2, 2015.
Mr. Frank will be deeply missed, said Seamus Lagan, Chief
Executive Officer of the Company. He was a great friend and his
wise counsel and deep insight into the business of the Company
were always of great value to me and the Board as a whole.
About Rennova Health, Inc. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc. Rennova Health, Inc. (NASDAQ:RNVA) Recent Trading Information
Rennova Health, Inc. (NASDAQ:RNVA) closed its last trading session down -0.0035 at 0.0880 with 4,912,351 shares trading hands.